KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,382,641 | $85,102,000 | 10.19% |
Consonance Capital Management LP | 890,209 | $54,792,000 | 5.84% |
CHI Advisors LLC | 400,468 | $24,649,000 | 4.94% |
Fairmount Funds Management LLC | 109,333 | $6,729,000 | 2.84% |
VR Adviser, LLC | 372,306 | $22,915,000 | 2.49% |
Opaleye Management Inc. | 157,500 | $9,694,000 | 1.42% |
Darwin Global Management, Ltd. | 86,887 | $5,348,000 | 1.05% |
Orbimed Advisors | 1,679,417 | $103,368,000 | 0.97% |
Nantahala Capital Management | 460,372 | $28,336,000 | 0.83% |
Eventide Asset Management | 427,414 | $26,307,000 | 0.39% |